| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | KDM3A ZNF609 ZNF274 ATRX GATA2 KDM3B SSRP1 SKIL PPARGC1A MLH3 ATXN7 BHLHE22 CHD6 ASXL2 POLQ KDM6A OBI1 CRTC2 L3MBTL4 | 4.34e-06 | 739 | 154 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | AGAP5 ABCA1 ATP8B4 ATRX ATAD5 AGAP11 BLM MLH3 CHD6 AGAP7P MTREX POLQ AGAP4 AGAP6 HSPA9 AGAP1 AGAP2 DNAH11 | 3.07e-05 | 775 | 154 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.73e-05 | 262 | 154 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 5.84e-05 | 127 | 154 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 6.03e-05 | 28 | 154 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | AGAP5 ABCA1 ATP8B4 ATRX ATAD5 AGAP11 BLM MLH3 CHD6 AGAP7P MTREX POLQ AGAP4 AGAP6 HSPA9 AGAP1 AGAP2 DNAH11 | 8.53e-05 | 839 | 154 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | AGAP5 ABCA1 ATP8B4 ATRX ATAD5 AGAP11 BLM MLH3 CHD6 AGAP7P MTREX POLQ AGAP4 AGAP6 HSPA9 AGAP1 AGAP2 DNAH11 | 8.66e-05 | 840 | 154 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | AGAP5 ABCA1 ATP8B4 ATRX ATAD5 AGAP11 BLM MLH3 CHD6 AGAP7P MTREX POLQ AGAP4 AGAP6 HSPA9 AGAP1 AGAP2 DNAH11 | 8.66e-05 | 840 | 154 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | histone demethylase activity | 9.10e-05 | 31 | 154 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | phospholipid binding | AGAP5 ABCA1 ZFYVE16 APBA1 AGAP11 ASAP1 KCNH1 SVIL AGAP7P NCF1C NCF1B AGAP4 AGAP6 AGAP1 | 9.10e-05 | 548 | 154 | 14 | GO:0005543 |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.03e-04 | 32 | 154 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | AGAP5 IPO7 AGAP11 ASAP1 RGL1 RUNDC3A AGAP7P SMAP2 FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 1.58e-04 | 507 | 154 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | AGAP5 IPO7 AGAP11 ASAP1 RGL1 RUNDC3A AGAP7P SMAP2 FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 1.58e-04 | 507 | 154 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | CCR4-NOT complex binding | 1.76e-04 | 3 | 154 | 2 | GO:1905762 | |
| GeneOntologyMolecularFunction | helicase activity | 2.28e-04 | 158 | 154 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.23e-04 | 279 | 154 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | satellite DNA binding | 3.51e-04 | 4 | 154 | 2 | GO:0003696 | |
| GeneOntologyMolecularFunction | demethylase activity | 3.63e-04 | 44 | 154 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 5.82e-04 | 5 | 154 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ATP8B4 ATRX ATAD5 BLM MLH3 CHD6 MTREX POLQ HSPA9 DNAH11 | 6.40e-04 | 441 | 154 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ATP8B4 ATRX ATAD5 DICER1 BLM MLH3 ERCC6L2 CHD6 MTREX POLQ HSPA9 DNAH11 | 9.65e-04 | 614 | 154 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | centromeric DNA binding | 1.21e-03 | 7 | 154 | 2 | GO:0019237 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ATRX ATAD5 DICER1 BLM MLH3 ERCC6L2 MARF1 DCLRE1A CHD6 HARS1 MTREX POLQ MBD4 | 1.50e-03 | 645 | 154 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 1.60e-03 | 65 | 154 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | enzyme activator activity | AGAP5 APAF1 AGAP11 ASAP1 CDK5R1 AGAP7P SMAP2 NCF1C NCF1B AGAP4 AGAP6 AGAP1 AGAP2 | 1.74e-03 | 656 | 154 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | DNA nuclease activity | 1.79e-03 | 67 | 154 | 4 | GO:0004536 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 2.05e-03 | 9 | 154 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 2.55e-03 | 10 | 154 | 2 | GO:0016176 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.88e-03 | 37 | 154 | 3 | GO:0140658 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | KDM3A ZNF845 ZNF609 AHI1 CAND1 ATRX GATA2 ZNF267 PRDM5 DICER1 E2F8 ZFPM2 PPARGC1A PRDM9 SENP1 MBTPS2 ATXN7 BHLHE22 PITX1 GMEB1 CHD6 ASXL2 KDM6A CRTC2 AGAP2 FOXP3 | 1.26e-05 | 1390 | 154 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.78e-05 | 109 | 154 | 7 | GO:0090630 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ATRX ATAD5 APAF1 SSRP1 USP37 DICER1 E2F8 BLM FANCB NEK2 PRDM9 MLH3 ATXN7 ERCC6L2 MARF1 KDM2A DCLRE1A POLQ MBD4 OBI1 FOXP3 | 5.56e-05 | 1081 | 154 | 21 | GO:0006259 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | IL12B AGAP5 APAF1 AGAP11 F2R GRAMD4 ASAP1 NEK2 JTB CDK5R1 SENP1 CD86 DSTYK ASXL2 AGAP7P AGAP4 AGAP6 CAP1 AGAP1 AGAP2 | 8.31e-05 | 1028 | 154 | 20 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 9.36e-05 | 244 | 154 | 9 | GO:0043547 | |
| GeneOntologyBiologicalProcess | DNA damage response | ARMT1 ATRX ATAD5 SSRP1 SKIL BLM FANCB PRDM9 MLH3 MBTPS2 ATXN7 ERCC6L2 MARF1 KDM2A DCLRE1A MTREX POLQ MBD4 DYRK3 | 1.00e-04 | 959 | 154 | 19 | GO:0006974 |
| GeneOntologyCellularComponent | midbody | IL16 DCDC1 CENPC STK17B MAP10 NEK2 JTB SH3GLB1 SVIL CEP126 AGAP2 | 8.58e-07 | 222 | 155 | 11 | GO:0030496 |
| GeneOntologyCellularComponent | Flemming body | 1.42e-04 | 36 | 155 | 4 | GO:0090543 | |
| MousePheno | fused cornea and lens | 2.92e-08 | 24 | 113 | 6 | MP:0001307 | |
| MousePheno | abnormal pinna reflex | 1.72e-05 | 101 | 113 | 7 | MP:0001485 | |
| MousePheno | abnormal lens development | 3.91e-05 | 78 | 113 | 6 | MP:0005545 | |
| MousePheno | increased circulating potassium level | 5.53e-05 | 121 | 113 | 7 | MP:0005627 | |
| MousePheno | abnormal skin morphology | KDM3A AGAP5 ZNF609 CAND1 IPO7 RNF135 KDM3B MUC5B AGAP11 PRDM5 ZFPM2 BLM JTB SENP1 BHLHE22 MKI67 TMPO CHD6 AGAP7P NCF1C NCF1B AGAP4 AGAP6 AGAP1 BRWD1 FOXP3 | 7.63e-05 | 1455 | 113 | 26 | MP:0002060 |
| MousePheno | absent pinna reflex | 8.23e-05 | 89 | 113 | 6 | MP:0006358 | |
| MousePheno | abnormal skin coloration | 1.13e-04 | 182 | 113 | 8 | MP:0011239 | |
| Domain | ArfGap | 1.01e-12 | 29 | 151 | 9 | SM00105 | |
| Domain | ARFGAP | 1.01e-12 | 29 | 151 | 9 | PS50115 | |
| Domain | ArfGap | 1.01e-12 | 29 | 151 | 9 | PF01412 | |
| Domain | ArfGAP | 1.01e-12 | 29 | 151 | 9 | IPR001164 | |
| Domain | ANK | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 6.36e-06 | 251 | 151 | 11 | SM00248 |
| Domain | ANK_REPEAT | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 6.86e-06 | 253 | 151 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 7.12e-06 | 254 | 151 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 7.12e-06 | 254 | 151 | 11 | PS50297 |
| Domain | Ankyrin_rpt | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 9.54e-06 | 262 | 151 | 11 | IPR002110 |
| Domain | PH_dom-like | AGAP5 FRMPD1 APBA1 AGAP11 SSRP1 ASAP1 MPRIP MTMR3 AGAP7P FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 9.62e-06 | 426 | 151 | 14 | IPR011993 |
| Domain | Helicase_C | 2.61e-05 | 107 | 151 | 7 | PF00271 | |
| Domain | HELICc | 2.61e-05 | 107 | 151 | 7 | SM00490 | |
| Domain | Helicase_C | 2.77e-05 | 108 | 151 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 2.94e-05 | 109 | 151 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.94e-05 | 109 | 151 | 7 | PS51192 | |
| Domain | DEXDc | 2.94e-05 | 109 | 151 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.12e-05 | 110 | 151 | 7 | IPR014001 | |
| Domain | - | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 3.46e-05 | 248 | 151 | 10 | 1.25.40.20 |
| Domain | JmjC | 3.85e-05 | 24 | 151 | 4 | PF02373 | |
| Domain | Ank_2 | 6.46e-05 | 215 | 151 | 9 | PF12796 | |
| Domain | PP1_bind | 6.49e-05 | 2 | 151 | 2 | PF15276 | |
| Domain | PP1-bd | 6.49e-05 | 2 | 151 | 2 | IPR029334 | |
| Domain | - | AGAP5 APBA1 AGAP11 SSRP1 ASAP1 MPRIP MTMR3 FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 8.21e-05 | 391 | 151 | 12 | 2.30.29.30 |
| Domain | PH | AGAP5 AGAP11 ASAP1 MPRIP AGAP7P FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 9.01e-05 | 278 | 151 | 10 | SM00233 |
| Domain | PH_DOMAIN | AGAP5 AGAP11 ASAP1 MPRIP AGAP7P FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 9.28e-05 | 279 | 151 | 10 | PS50003 |
| Domain | PH_domain | AGAP5 AGAP11 ASAP1 MPRIP AGAP7P FGD6 AGAP4 AGAP6 AGAP1 AGAP2 | 9.56e-05 | 280 | 151 | 10 | IPR001849 |
| Domain | Ank | ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP1 AGAP2 | 1.01e-04 | 228 | 151 | 9 | PF00023 |
| Domain | - | 1.08e-04 | 12 | 151 | 3 | 3.10.390.10 | |
| Domain | SAND_dom-like | 1.08e-04 | 12 | 151 | 3 | IPR010919 | |
| Domain | JMJC | 1.24e-04 | 32 | 151 | 4 | PS51184 | |
| Domain | JmjC_dom | 1.24e-04 | 32 | 151 | 4 | IPR003347 | |
| Domain | JmjC | 1.40e-04 | 33 | 151 | 4 | SM00558 | |
| Domain | FRG2 | 1.94e-04 | 3 | 151 | 2 | PF15315 | |
| Domain | FRG2 | 1.94e-04 | 3 | 151 | 2 | IPR026245 | |
| Domain | Znf_FYVE_PHD | 1.94e-04 | 147 | 151 | 7 | IPR011011 | |
| Domain | Znf_C2H2-like | ZNF845 ZNF609 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 ATXN7 RBAK ZNF286B FBXO41 FOXP3 | 2.47e-04 | 796 | 151 | 17 | IPR015880 |
| Domain | Znf_C2H2 | ZNF845 ZNF609 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 ATXN7 RBAK ZNF286B FBXO41 FOXP3 | 2.81e-04 | 805 | 151 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF845 ZNF609 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 ATXN7 RBAK ZNF286B FBXO41 FOXP3 | 2.94e-04 | 808 | 151 | 17 | SM00355 |
| Domain | PH | 5.59e-04 | 229 | 151 | 8 | PF00169 | |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF845 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 RBAK ZNF286B FOXP3 | 1.52e-03 | 694 | 151 | 14 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF845 ZNF609 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 RBAK ZNF286B FOXP3 | 1.56e-03 | 775 | 151 | 15 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF845 ZNF609 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 RBAK ZNF286B FOXP3 | 1.60e-03 | 777 | 151 | 15 | PS00028 |
| Domain | FYVE | 1.62e-03 | 29 | 151 | 3 | PF01363 | |
| Domain | FYVE | 1.62e-03 | 29 | 151 | 3 | SM00064 | |
| Domain | SAND_dom | 1.76e-03 | 8 | 151 | 2 | IPR000770 | |
| Domain | SAND | 1.76e-03 | 8 | 151 | 2 | PF01342 | |
| Domain | SAND | 1.76e-03 | 8 | 151 | 2 | PS50864 | |
| Domain | SAND | 1.76e-03 | 8 | 151 | 2 | SM00258 | |
| Domain | SNF2_N | 2.16e-03 | 32 | 151 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.16e-03 | 32 | 151 | 3 | PF00176 | |
| Domain | Znf_FYVE-rel | 2.58e-03 | 34 | 151 | 3 | IPR017455 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.80e-03 | 35 | 151 | 3 | IPR002464 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.90e-03 | 73 | 151 | 4 | IPR011545 | |
| Domain | DEAD | 2.90e-03 | 73 | 151 | 4 | PF00270 | |
| Domain | - | ZNF845 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF10 ZNF430 PRDM9 ZNF532 RBAK ZNF286B FOXP3 | 3.50e-03 | 679 | 151 | 13 | 3.30.160.60 |
| Domain | Znf_FYVE | 3.55e-03 | 38 | 151 | 3 | IPR000306 | |
| Domain | DEAH_ATP_HELICASE | 3.55e-03 | 38 | 151 | 3 | PS00690 | |
| Domain | ZF_FYVE | 4.11e-03 | 40 | 151 | 3 | PS50178 | |
| Domain | zf-C2H2 | ZNF845 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 RBAK ZNF286B FBXO41 | 4.16e-03 | 693 | 151 | 13 | PF00096 |
| Domain | MIRO-like | 4.78e-03 | 13 | 151 | 2 | IPR013684 | |
| Domain | I-BAR_dom | 4.78e-03 | 13 | 151 | 2 | IPR013606 | |
| Domain | Roc | 4.78e-03 | 13 | 151 | 2 | PF08477 | |
| Domain | GATA_ZN_FINGER_1 | 7.23e-03 | 16 | 151 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 7.23e-03 | 16 | 151 | 2 | PS50114 | |
| Domain | RmlC_Cupin | 7.23e-03 | 16 | 151 | 2 | IPR011051 | |
| Domain | ZF_PHD_2 | 7.40e-03 | 95 | 151 | 4 | PS50016 | |
| Domain | - | ABCA1 ATRX ATAD5 APAF1 DICER1 BLM ERCC6L2 CHD6 MTREX POLQ AGAP1 AGAP2 DNAH11 | 7.59e-03 | 746 | 151 | 13 | 3.40.50.300 |
| Domain | ZF_PHD_1 | 7.67e-03 | 96 | 151 | 4 | PS01359 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 4.56e-05 | 29 | 98 | 4 | MM14934 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.19e-15 | 9 | 157 | 7 | 12640130 | |
| Pubmed | KDM3A AGAP5 ZNF609 CAND1 SRRM4 HECTD4 KDM3B AGAP11 WDR37 DICER1 GRAMD4 ZNF532 FBXO41 PCNX1 CEP126 AGAP7P MTREX AGAP4 AGAP6 GARRE1 AGAP1 | 4.18e-14 | 529 | 157 | 21 | 14621295 | |
| Pubmed | 1.12e-13 | 14 | 157 | 7 | 22453919 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.59e-12 | 10 | 157 | 6 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 3.49e-12 | 11 | 157 | 6 | 15381706 | |
| Pubmed | 1.28e-11 | 13 | 157 | 6 | 27713690 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KDM3A ZNF845 IPO7 ATRX CENPC ATAD5 KDM3B SSRP1 BLM CDCA2 RBAK PITX1 MKI67 TMPO KDM2A CHD6 MBD4 BRWD1 | 3.64e-10 | 608 | 157 | 18 | 36089195 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF845 ZNF609 ATRX ATAD5 GATA2 SSRP1 SKIL SP110 BLM ARL6IP4 CDCA2 MACO1 PITX1 MKI67 TMPO KDM2A DCLRE1A CHD6 ASXL2 MTREX MBD4 KDM6A HSPA9 | 2.14e-08 | 1294 | 157 | 23 | 30804502 |
| Pubmed | GPD2 ARMT1 ZNF609 IPO7 CENPC ZFYVE16 ATAD5 ASAP1 BLM CDCA2 MACO1 SVIL MKI67 MTMR3 TMPO ELP2 CRYBG3 HARS1 ANKRD52 KDM6A | 6.30e-08 | 1049 | 157 | 20 | 27880917 | |
| Pubmed | KDM3A ZNF845 ZNF609 CAND1 IPO7 KDM3B SSRP1 E2F8 ARL6IP4 RBAK PITX1 MKI67 GMEB1 TMPO ASXL2 MTREX KDM6A HSPA9 CAP1 | 6.42e-07 | 1103 | 157 | 19 | 34189442 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | AGAP5 CAND1 WDR7 AGAP11 ASAP1 AGAP7P AGAP4 AGAP6 AGAP1 AGAP2 | 6.66e-07 | 281 | 157 | 10 | 28706196 |
| Pubmed | IL16 ZNF609 DCDC1 ATAD5 SSRP1 SKIL PRDM5 WDR37 SP110 DICER1 ZNF518A ARL6IP4 SENP1 MLH3 ATXN7 CRYBG3 ANKRD52 GARRE1 BRWD1 | 7.65e-07 | 1116 | 157 | 19 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM3B SSRP1 E2F8 MPRIP CDCA2 DSTYK SVIL ZNF286B CRYBG3 MTREX CAMSAP1 SMAP2 FGD6 OBI1 GARRE1 CRTC2 | 1.99e-06 | 861 | 157 | 16 | 36931259 |
| Pubmed | 3.50e-06 | 90 | 157 | 6 | 15033168 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 5.64e-06 | 357 | 157 | 10 | 37059091 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.19e-06 | 218 | 157 | 8 | 33378226 | |
| Pubmed | 7.24e-06 | 102 | 157 | 6 | 10231032 | ||
| Pubmed | NEPRO ZNF609 ATRX ATAD5 GATA2 ZFPM2 MPRIP BLM CDCA2 ATXN7 SVIL PITX1 MKI67 MARF1 GMEB1 CHD6 ASXL2 SMAP2 KDM6A GARRE1 | 7.45e-06 | 1429 | 157 | 20 | 35140242 | |
| Pubmed | Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. | 1.45e-05 | 11 | 157 | 3 | 15908387 | |
| Pubmed | 1.48e-05 | 33 | 157 | 4 | 22844247 | ||
| Pubmed | 1.52e-05 | 116 | 157 | 6 | 30652415 | ||
| Pubmed | SEC16B ATP8B4 ANKRD62 USP37 RGL1 AHRR SH3GLB1 DSTYK ZNF286B KDM2A FGD6 | 1.62e-05 | 493 | 157 | 11 | 15368895 | |
| Pubmed | ATRX ZFYVE16 KDM3B SKIL ZNF518A MACO1 GMEB1 KDM2A CHD6 ASXL2 CAMSAP1 KDM6A | 1.69e-05 | 591 | 157 | 12 | 15231748 | |
| Pubmed | 1.94e-05 | 250 | 157 | 8 | 33536335 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12388557 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22801545 | ||
| Pubmed | The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3. | 2.02e-05 | 2 | 157 | 2 | 16079295 | |
| Pubmed | High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer. | 2.02e-05 | 2 | 157 | 2 | 23266046 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28738472 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26086043 | ||
| Pubmed | CRTC2 enhances HBV transcription and replication by inducing PGC1α expression. | 2.02e-05 | 2 | 157 | 2 | 24529027 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36249417 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27496732 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28569748 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19470682 | ||
| Pubmed | KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis. | 2.02e-05 | 2 | 157 | 2 | 31629659 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 3875483 | ||
| Pubmed | A structural basis for immunodominant human T cell receptor recognition. | 2.02e-05 | 2 | 157 | 2 | 12796775 | |
| Pubmed | Dicer-dependent microRNA pathway safeguards regulatory T cell function. | 2.02e-05 | 2 | 157 | 2 | 18725526 | |
| Pubmed | SUMO-specific protease 1 regulates mitochondrial biogenesis through PGC-1α. | 2.02e-05 | 2 | 157 | 2 | 23152500 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28430047 | ||
| Pubmed | KDM3A CAND1 ATRX HECTD4 APBA1 SKIL MPRIP ZNF532 MTMR3 CHD6 HARS1 MBD4 PLP1 KDM6A HSPA9 AGAP1 AGAP2 BRWD1 | 2.18e-05 | 1285 | 157 | 18 | 35914814 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ABCA1 TOPAZ1 SRRM4 SSRP1 KRTAP16-1 MTMR3 PCNX1 CHD6 HSPA9 DYRK3 | 2.29e-05 | 420 | 157 | 10 | 28065597 |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 2.35e-05 | 37 | 157 | 4 | 36835656 | |
| Pubmed | 2.50e-05 | 13 | 157 | 3 | 15240714 | ||
| Pubmed | 2.55e-05 | 339 | 157 | 9 | 30415952 | ||
| Pubmed | 2.65e-05 | 128 | 157 | 6 | 30995482 | ||
| Pubmed | AGAP5 FRMPD1 AGAP11 RUNDC3A FBXO41 AGAP7P AGAP4 AGAP6 AGAP1 AGAP2 | 2.80e-05 | 430 | 157 | 10 | 32581705 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX HECTD4 SSRP1 DICER1 MPRIP BLM CDCA2 MKI67 MTREX CAMSAP1 | 3.40e-05 | 440 | 157 | 10 | 34244565 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | PRPSAP1 AGAP5 AGAP11 DICER1 GRAMD4 SVIL AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 | 3.48e-05 | 536 | 157 | 11 | 15840001 |
| Pubmed | PRPSAP1 AGAP5 AGAP11 DICER1 GRAMD4 SVIL AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 | 3.60e-05 | 538 | 157 | 11 | 10512203 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 4.16e-05 | 361 | 157 | 9 | 30344098 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 4.34e-05 | 363 | 157 | 9 | 14691545 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 17512541 | ||
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 6.06e-05 | 3 | 157 | 2 | 27044504 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 6.06e-05 | 3 | 157 | 2 | 18787174 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 24873968 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 22184329 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 6.06e-05 | 3 | 157 | 2 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 6.06e-05 | 3 | 157 | 2 | 20142487 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 6.06e-05 | 3 | 157 | 2 | 25565313 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 39357591 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 11435342 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 31118934 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 16041040 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 25131111 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 6.06e-05 | 3 | 157 | 2 | 18703411 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 17307863 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 6.06e-05 | 3 | 157 | 2 | 27829407 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 22376231 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 6.06e-05 | 3 | 157 | 2 | 28274989 | |
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 6.06e-05 | 3 | 157 | 2 | 12364355 | |
| Pubmed | USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM. | 6.06e-05 | 3 | 157 | 2 | 34606619 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 34557202 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 28467721 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 10670582 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 6.06e-05 | 3 | 157 | 2 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 6.06e-05 | 3 | 157 | 2 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 6.06e-05 | 3 | 157 | 2 | 23328631 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 22356911 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 34572995 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 17114280 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 25989352 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 17404617 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 17332431 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 36592568 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 30504842 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 23266085 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 16237117 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 6.06e-05 | 3 | 157 | 2 | 23965970 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 15513930 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 15033459 | ||
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 6.06e-05 | 3 | 157 | 2 | 20828610 | |
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 20817944 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 36853827 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 23024271 | ||
| Pubmed | 6.06e-05 | 3 | 157 | 2 | 21253614 | ||
| Interaction | H3C3 interactions | KDM3A ZNF845 IPO7 ATRX CENPC ATAD5 KDM3B SSRP1 BLM CDCA2 PITX1 MKI67 TMPO KDM2A CHD6 MBD4 | 1.10e-06 | 495 | 152 | 16 | int:H3C3 |
| Interaction | NLE1 interactions | 9.32e-06 | 228 | 152 | 10 | int:NLE1 | |
| Interaction | NUP43 interactions | KDM3A NEPRO ZNF609 CENPC SSRP1 ZNF518A BLM ARL6IP4 CDCA2 SENP1 ZNF532 MKI67 MARF1 KDM2A CHD6 ASXL2 | 2.09e-05 | 625 | 152 | 16 | int:NUP43 |
| GeneFamily | ArfGAPs | 2.17e-13 | 33 | 107 | 9 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.86e-12 | 17 | 107 | 7 | 1291 | |
| GeneFamily | Ankyrin repeat domain containing | AGAP5 ANKRD62 AGAP11 ASAP1 ANKRD30A AGAP7P AGAP4 ANKRD52 AGAP6 AGAP1 AGAP2 | 1.97e-07 | 242 | 107 | 11 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.72e-06 | 206 | 107 | 9 | 682 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.12e-05 | 24 | 107 | 4 | 485 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.21e-05 | 11 | 107 | 3 | 1168 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF845 ZNF609 ZNF274 ZNF267 ZNF429 PRDM5 ZFPM2 ZNF518A ZNF10 ZNF430 PRDM9 ZNF532 RBAK ZNF286B | 8.52e-05 | 718 | 107 | 14 | 28 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.26e-04 | 181 | 107 | 6 | 694 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 8.03e-04 | 31 | 107 | 3 | 81 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 4.45e-03 | 17 | 107 | 2 | 1197 | |
| GeneFamily | WD repeat domain containing | 4.67e-03 | 262 | 107 | 6 | 362 | |
| Coexpression | FISCHER_DREAM_TARGETS | GPD2 AHI1 CAND1 CENPC ATAD5 STK17B ZNF267 SSRP1 USP37 E2F8 ZNF518A BLM CDCA2 FANCB NEK2 SENP1 MKI67 TMPO DCLRE1A POLQ OBI1 HSPA9 | 7.45e-08 | 969 | 156 | 22 | M149 |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 8.06e-08 | 37 | 156 | 6 | MM1121 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 2.36e-07 | 44 | 156 | 6 | MM485 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | AHI1 CAND1 ATAD5 SSRP1 USP37 E2F8 BLM CDCA2 NEK2 CDK5R1 SENP1 RUNDC3A MKI67 TMPO CAMSAP1 MBD4 | 3.24e-06 | 680 | 156 | 16 | MM456 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | PRPSAP1 TCTN3 CAND1 IPO7 WDR7 APAF1 HECTD4 KDM3B DICER1 CD86 TMPO KDM2A CAP1 | 5.99e-06 | 477 | 156 | 13 | M40930 |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 1.26e-05 | 236 | 156 | 9 | M130 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A CAND1 IPO7 ATRX CENPC ZFYVE16 WDR7 KDM3B WDR37 DICER1 BLM RGL1 MTMR3 CRYBG3 MTREX GARRE1 AGAP1 | 1.46e-05 | 856 | 156 | 17 | M4500 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 2.30e-05 | 195 | 156 | 8 | M13736 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP | 2.76e-05 | 200 | 156 | 8 | M4626 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 2.76e-05 | 200 | 156 | 8 | M6661 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KDM3A ABCA1 AHI1 ZNF274 STK17B SKIL RGL1 MTMR3 GMEB1 PCNX1 KDM2A FGD6 KDM6A GARRE1 DYRK3 BRWD1 | 3.37e-05 | 822 | 156 | 16 | M6782 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 7.41e-05 | 230 | 156 | 8 | M11563 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | GPD2 IPO7 ATAD5 SSRP1 USP37 DICER1 E2F8 ASAP1 BLM CDCA2 NEK2 COA6 MKI67 TMPO POLQ MBD4 OBI1 HSPA9 AGAP1 DYRK3 | 8.54e-05 | 1290 | 156 | 20 | M80 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 8.54e-05 | 174 | 156 | 7 | M2996 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | PRPSAP1 ATP8B4 SELENBP1 WDR7 STK17B GRAMD4 RGL1 MACO1 PITX1 FAM217B CRYBG3 SMAP2 FGD6 AGAP1 | 1.18e-04 | 726 | 156 | 14 | M4210 |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 1.53e-04 | 191 | 156 | 7 | M2148 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.55e-04 | 402 | 156 | 10 | MM454 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 1.90e-04 | 198 | 156 | 7 | M8628 | |
| Coexpression | GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN | 1.96e-04 | 199 | 156 | 7 | M8094 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP | 1.96e-04 | 199 | 156 | 7 | M6183 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 2.02e-04 | 200 | 156 | 7 | M8050 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 2.02e-04 | 200 | 156 | 7 | M8088 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP | 2.02e-04 | 200 | 156 | 7 | M3573 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | 2.02e-04 | 200 | 156 | 7 | M3404 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN | 2.02e-04 | 200 | 156 | 7 | M8956 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 2.02e-04 | 200 | 156 | 7 | M7869 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN | 2.02e-04 | 200 | 156 | 7 | M5705 | |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_UP | 2.02e-04 | 200 | 156 | 7 | M5727 | |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 2.04e-04 | 141 | 156 | 6 | M465 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | IL16 ZNF609 WWC3 ATRX CENPC STK17B HECTD4 GATA2 F2R SP110 DICER1 ASAP1 ATXN7 DSTYK PCNX1 KDM2A ASXL2 GPR171 SMAP2 CAP1 BRWD1 | 2.15e-04 | 1492 | 156 | 21 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | KDM3A ABCA1 CAND1 ZNF274 CENPC DICER1 ZNF430 ATXN7 MARF1 TMPO KDM6A HSPA9 BRWD1 | 2.25e-04 | 680 | 156 | 13 | M41089 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | AHI1 IPO7 ATRX ATAD5 DICER1 ZNF518A BLM MKI67 POLQ FGD6 KDM6A | 1.45e-05 | 311 | 151 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.12e-05 | 79 | 151 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | NEPRO AHI1 CAND1 ATRX ATAD5 APAF1 ZNF429 SSRP1 PRDM5 WDR37 GRAMD4 ZFPM2 CDCA2 RGL1 ERCC6L2 PRR14L FGD6 BRWD1 | 2.18e-05 | 819 | 151 | 18 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | GPD2 CADM3 ZNF609 AHI1 ATRX CENPC ATAD5 USP37 WDR37 E2F8 CDCA2 PPARGC1A NEK2 PRDM9 RUNDC3A MKI67 PACC1 CEP126 CAMSAP1 MBD4 KDM6A OBI1 DYRK3 BRWD1 | 3.69e-05 | 1370 | 151 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3 | ATP8B4 ATAD5 SSRP1 F2R GRAMD4 E2F8 BLM RGL1 HEATR9 MKI67 GPR171 | 6.58e-05 | 367 | 151 | 11 | GSM538309_500 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.99e-08 | 193 | 157 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 3.26e-08 | 195 | 157 | 9 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 3.26e-08 | 195 | 157 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.26e-08 | 195 | 157 | 9 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 7.79e-08 | 154 | 157 | 8 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-07 | 177 | 157 | 8 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-07 | 177 | 157 | 8 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.93e-07 | 183 | 157 | 8 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-07 | 187 | 157 | 8 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.06e-07 | 191 | 157 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.56e-07 | 194 | 157 | 8 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.93e-07 | 196 | 157 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.93e-07 | 196 | 157 | 8 | b237287def04def371191b054a41ec0b3150da75 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.13e-07 | 197 | 157 | 8 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.13e-07 | 197 | 157 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 5.25e-07 | 135 | 157 | 7 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-07 | 198 | 157 | 8 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-07 | 198 | 157 | 8 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-07 | 198 | 157 | 8 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-07 | 198 | 157 | 8 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.33e-07 | 198 | 157 | 8 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 5.53e-07 | 199 | 157 | 8 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 199 | 157 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.75e-07 | 200 | 157 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.75e-07 | 200 | 157 | 8 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.75e-07 | 200 | 157 | 8 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.75e-07 | 200 | 157 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.75e-07 | 200 | 157 | 8 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.75e-07 | 200 | 157 | 8 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.75e-07 | 200 | 157 | 8 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.75e-07 | 200 | 157 | 8 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.75e-07 | 200 | 157 | 8 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.75e-07 | 200 | 157 | 8 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-06 | 152 | 157 | 7 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 1.71e-06 | 161 | 157 | 7 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-06 | 166 | 157 | 7 | 9e916fc1858573358e1eb5e3789b2c9f8ef74476 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 168 | 157 | 7 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 169 | 157 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 171 | 157 | 7 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 171 | 157 | 7 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-06 | 172 | 157 | 7 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.87e-06 | 174 | 157 | 7 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.87e-06 | 174 | 157 | 7 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-06 | 174 | 157 | 7 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.87e-06 | 174 | 157 | 7 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 2.87e-06 | 174 | 157 | 7 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-06 | 175 | 157 | 7 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 3.09e-06 | 176 | 157 | 7 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-06 | 180 | 157 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 182 | 157 | 7 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 3.86e-06 | 182 | 157 | 7 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.00e-06 | 183 | 157 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 183 | 157 | 7 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 183 | 157 | 7 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.15e-06 | 184 | 157 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 4.30e-06 | 185 | 157 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-06 | 185 | 157 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-06 | 186 | 157 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-06 | 187 | 157 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.95e-06 | 189 | 157 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.12e-06 | 190 | 157 | 7 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-06 | 190 | 157 | 7 | 373629dde5eda722424c5e6087763f0c5db67cf4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.30e-06 | 191 | 157 | 7 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.30e-06 | 191 | 157 | 7 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.68e-06 | 193 | 157 | 7 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.87e-06 | 194 | 157 | 7 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.87e-06 | 194 | 157 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 195 | 157 | 7 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 195 | 157 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 195 | 157 | 7 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.07e-06 | 195 | 157 | 7 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.07e-06 | 195 | 157 | 7 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 195 | 157 | 7 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.07e-06 | 195 | 157 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 195 | 157 | 7 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.28e-06 | 196 | 157 | 7 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.28e-06 | 196 | 157 | 7 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.28e-06 | 196 | 157 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.28e-06 | 196 | 157 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.28e-06 | 196 | 157 | 7 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.49e-06 | 197 | 157 | 7 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.49e-06 | 197 | 157 | 7 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.49e-06 | 197 | 157 | 7 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.49e-06 | 197 | 157 | 7 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.49e-06 | 197 | 157 | 7 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.49e-06 | 197 | 157 | 7 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.49e-06 | 197 | 157 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 129 | 157 | 6 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.71e-06 | 198 | 157 | 7 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 6.71e-06 | 198 | 157 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.71e-06 | 198 | 157 | 7 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.71e-06 | 198 | 157 | 7 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.71e-06 | 198 | 157 | 7 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 6.71e-06 | 198 | 157 | 7 | c65cdb54409087014125a76627e5efb5fe8dabc9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 198 | 157 | 7 | 55ea8c9d2154ded74c7b851735b24c95bae01de4 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-06 | 198 | 157 | 7 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.71e-06 | 198 | 157 | 7 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 198 | 157 | 7 | fc7d8b8e710eedd6cfc1e5393f0c23feac283807 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-06 | 198 | 157 | 7 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 7.58e-06 | 194 | 155 | 9 | 4309_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 8.23e-06 | 196 | 155 | 9 | 6934_UP | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A | 8.57e-06 | 197 | 155 | 9 | 4771_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; HL60; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 2182_DN | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.97e-12 | 10 | 148 | 6 | DOID:1969 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | GPC1 KDM3A FRMPD1 SP110 RGL1 ZNF532 KCNH1 HEATR9 MKI67 MTMR3 FAM217B ANKRD30A MROH7 PACC1 AGAP2 FOXP3 | 1.03e-04 | 1074 | 148 | 16 | C0006142 |
| Disease | Inherited acute myeloid leukemia | 1.49e-04 | 4 | 148 | 2 | C4707228 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 2.47e-04 | 5 | 148 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.64e-04 | 67 | 148 | 4 | C3463824 | |
| Disease | colorectal cancer (is_implicated_in) | 3.70e-04 | 121 | 148 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | visual epilepsy (implicated_via_orthology) | 6.60e-04 | 34 | 148 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 6.86e-04 | 8 | 148 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | low tension glaucoma | 8.79e-04 | 9 | 148 | 2 | EFO_1001022 | |
| Disease | aplastic anemia (is_marker_for) | 8.79e-04 | 9 | 148 | 2 | DOID:12449 (is_marker_for) | |
| Disease | fear of medical pain measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0008339 | |
| Disease | Carcinoma, Transitional Cell | 1.15e-03 | 41 | 148 | 3 | C0007138 | |
| Disease | obsolete_red blood cell distribution width | PRPSAP1 AHI1 SELENBP1 STK17B HECTD4 ZFPM2 CDCA2 NEK2 AHRR CATSPER2 ATXN7 DSTYK ASXL2 AGAP7P GARRE1 AGAP1 | 1.23e-03 | 1347 | 148 | 16 | EFO_0005192 |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.47e-03 | 97 | 148 | 4 | DOID:3083 (is_marker_for) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.60e-03 | 12 | 148 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Oligospermia | 1.60e-03 | 12 | 148 | 2 | C0028960 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 1.60e-03 | 46 | 148 | 3 | EFO_0008003, GO_0097332 | |
| Disease | Leukemia, Myelocytic, Acute | 1.84e-03 | 173 | 148 | 5 | C0023467 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | factor VII activating protease measurement | 2.68e-03 | 55 | 148 | 3 | EFO_0009368 | |
| Disease | Cardiovascular Abnormalities | 2.86e-03 | 16 | 148 | 2 | C0243050 | |
| Disease | Polydactyly | 2.91e-03 | 117 | 148 | 4 | C0152427 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 3.18e-03 | 120 | 148 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | respiratory symptom change measurement, response to placebo | 3.23e-03 | 17 | 148 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 3.63e-03 | 18 | 148 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Arsenic Induced Polyneuropathy | 3.77e-03 | 62 | 148 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 3.77e-03 | 62 | 148 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 3.77e-03 | 62 | 148 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 3.77e-03 | 62 | 148 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 3.77e-03 | 62 | 148 | 3 | C0274862 | |
| Disease | colorectal cancer, inflammatory bowel disease | 4.04e-03 | 19 | 148 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Familial aplasia of the vermis | 4.47e-03 | 20 | 148 | 2 | cv:C0431399 | |
| Disease | Parkinson's disease (is_marker_for) | 4.68e-03 | 67 | 148 | 3 | DOID:14330 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AATADAKVKATTSLC | 301 | A9YTQ3 | |
| TVSACESTASKSKKR | 291 | Q9NWW7 | |
| ASLQSCESSKSKSQL | 421 | Q96P64 | |
| STDDRFIATCSVDKK | 666 | O14727 | |
| SFTKCSSAISKALET | 1716 | Q96QE3 | |
| SSAISKALETLNSCK | 1721 | Q96QE3 | |
| SLLSNCKKTREKASA | 231 | Q9H993 | |
| ILASLQSCESSKSKS | 306 | Q8TF27 | |
| LQSCESSKNKSRLTS | 591 | Q9UPQ3 | |
| LKKSLSCANLSTFAQ | 86 | Q15078 | |
| EETLSKKREYQSSSC | 431 | Q96P56 | |
| KKREYQSSSCVSSTS | 436 | Q96P56 | |
| TSLSLDCKKLNFSIS | 641 | Q68DQ2 | |
| RSCAAKVNKNLSFTS | 991 | Q8N157 | |
| KSLSASTSKRLEAAF | 21 | Q8NFJ8 | |
| CFESSKSGSSKRNKV | 496 | Q6IC98 | |
| VKKDVESSLSSCRNS | 1131 | O95477 | |
| SCRNSSSTVSYLKKE | 1141 | O95477 | |
| SCDSRSLFESSAKIQ | 481 | Q9BXX3 | |
| ECKDFVSLSKSKNAT | 411 | A6NC57 | |
| SKNSLDCEIVSAKSS | 421 | Q01518 | |
| ACLDKLRTSFKTITS | 2356 | Q96DT5 | |
| CESSKVKLRTDSQSE | 916 | Q99490 | |
| ENLCKKTTDTVSSFS | 1171 | Q8TF62 | |
| SFSLLKNCSIAAAKT | 1031 | Q8NB46 | |
| SLREKDTATLNCQSS | 141 | Q8N126 | |
| QRVFKSSKTSSCDKS | 311 | P42081 | |
| CAAASVASSRSSVLK | 1621 | Q9UPY3 | |
| KSAARTCLSEISNST | 91 | Q96MF4 | |
| KLQRLNSCETKSSTS | 821 | Q5T5Y3 | |
| SRETLSTSDCLASKN | 1216 | Q76L83 | |
| STSDCLASKNVKAEI | 1221 | Q76L83 | |
| ASLQSCESSKSKSQL | 421 | Q5VW22 | |
| LSKKCADSSFTVLAE | 451 | Q9HC84 | |
| QSNSEDAFKCLSSKI | 146 | Q68CQ1 | |
| QKKLSESSSSCSSIH | 581 | Q9NZL6 | |
| CTAKSSLKESSRSFQ | 221 | Q9NQX1 | |
| SKNNSCSISASKRNR | 121 | M0R2J8 | |
| TSSLPEEKNKSSCSF | 491 | Q6WCQ1 | |
| SNCLKSSYVLSKSRA | 186 | P43304 | |
| KNILTCLASARSSTD | 291 | Q96P67 | |
| ESSAKSTCRSEAKKD | 436 | Q9P2G4 | |
| KSSHDRCLEKSSSSS | 281 | P42166 | |
| RSENSESQLTSKSKC | 396 | P51955 | |
| LTKASSVASSDKGSC | 266 | Q9BZS1 | |
| NTCRSTKFDLLISSA | 176 | Q9Y692 | |
| DDLCSRKVSRKSSSS | 496 | P35052 | |
| DLSKKCLSQSERTTT | 831 | Q8WW38 | |
| LNATRSKSCSNTSAL | 376 | O15550 | |
| SKSCSNTSALAARIK | 381 | O15550 | |
| LKRASSRCQSTKSAQ | 376 | P11801 | |
| DKSSSSNLKIDALSC | 486 | Q86VP6 | |
| TENLLKEDSCTASSK | 306 | Q8N5G2 | |
| NSCASDKRTSSEKIA | 441 | Q96RV3 | |
| TAAQTLLFTACSKRK | 391 | O95373 | |
| NSDSSRKDSKLCSVL | 901 | Q9UHC1 | |
| VILDSADSCKASKTQ | 331 | Q9NTX9 | |
| DCSTRISLFKAKEAT | 256 | O14626 | |
| RSQSCETKLLDEKTS | 971 | Q14005 | |
| ARQESTSKADLNCSK | 326 | Q5W0B1 | |
| NKKTSDASKRACNLT | 1346 | Q7LBC6 | |
| KTDSCDSGITKSDLR | 876 | O95259 | |
| SSLRQRKTQSCLKSS | 131 | Q2VPJ9 | |
| KEGSLNSVSSCTDRS | 126 | Q9H2C1 | |
| SDSSHSKSKSLCSLN | 431 | Q8NA19 | |
| DLTACSKLTDASLAK | 81 | Q8WV35 | |
| RRSCKTAPASSSKSQ | 596 | P46013 | |
| SCKESQSGFRKDSSL | 2596 | Q9Y4D8 | |
| AAEKAKCELSSSVQT | 311 | P38646 | |
| TDKTSATVICRKNAS | 291 | P29460 | |
| KRKCSPSSSSINNSS | 836 | O15265 | |
| LSASKLAKSICSQFR | 576 | Q6XUX3 | |
| LNRCSESTKRKLASA | 376 | A6NI72 | |
| LNRCSESTKRKLASA | 351 | A8MVU1 | |
| SCETRKSQSAKSLSF | 406 | Q16827 | |
| ASSSIRFSKACLKNV | 51 | Q9H813 | |
| CLSSSAVANRSKKSR | 296 | P25116 | |
| KDSLNSDCLTSFKIT | 346 | Q8NB91 | |
| TENRNSSRDKCTSKK | 226 | Q9UBK2 | |
| KASFSNESSLKELSR | 121 | Q9NQV7 | |
| SLPRTSTQSKFSKCD | 641 | Q5VYJ5 | |
| KECSLSLNKKSRSST | 116 | Q96QU4 | |
| KECSLSLNKKSRSST | 116 | Q64ET8 | |
| SSFTPKQRSKARSCS | 276 | P23769 | |
| LLGKSSRKRQDCSSS | 1096 | P46100 | |
| SRKRQDCSSSDTEKY | 1101 | P46100 | |
| SLKKTLAGDSSSDCS | 416 | Q9Y2K7 | |
| ISSCLNTKSEALRTK | 346 | Q9Y4C1 | |
| ASSSSSKCLSTLKDL | 311 | P54132 | |
| SKCLSTLKDLDTSDR | 316 | P54132 | |
| RRSSKENCAKNLFST | 371 | A0AVK6 | |
| AKKKNLDCSRSTRSS | 626 | Q03188 | |
| SCTDSAARTKSRKAS | 171 | Q8TD26 | |
| VSTCAVNSADTKKSR | 676 | Q9P2H0 | |
| DAKKLSSSSSRPRSC | 231 | Q53ET0 | |
| KSDSSSICLSAEKSF | 1281 | Q5SYB0 | |
| TRKSASCQADLASSL | 241 | O75417 | |
| FSKLTSRFTKKASCT | 536 | O15063 | |
| KSECSILLSKQTSDF | 671 | Q6ZRK6 | |
| ASLQSCESSKSKSQL | 421 | Q5VUJ5 | |
| KKSRKDTSRNCSAST | 26 | Q66PJ3 | |
| EASTNKESRKSLASF | 426 | Q02410 | |
| RFSRKTCSTSSAKLN | 551 | Q9ULH1 | |
| KISRKRVCSSDSDSS | 1896 | Q9NSI6 | |
| KKKERSLSSGSNFCS | 311 | O95243 | |
| ELFARKSVASSACST | 156 | Q8TF61 | |
| SFTPKNRELCETKSS | 581 | Q9Y4F3 | |
| CRTNKDCKKSSSSSF | 371 | O43462 | |
| SQKAKRRTICTFDSS | 916 | Q69YH5 | |
| KSFCISTLANTKATS | 976 | Q69YH5 | |
| FSANSTAACTELAKR | 11 | Q14558 | |
| SDSCKRDCKKSTSSQ | 456 | A8MUX0 | |
| SSQCKRKAEKSLSDL | 596 | Q6PJP8 | |
| NSSKTLLASACKAAK | 576 | Q6IA86 | |
| SFKDSTNKISQVCSL | 1326 | Q5T890 | |
| VSDSKFRTICSSVDK | 226 | P12081 | |
| SDCLNTVKSNSSSKA | 121 | O43781 | |
| SKDSLSRQLSAMSCS | 966 | Q13615 | |
| CSASAAFKSSKISLQ | 801 | Q5THK1 | |
| DLSSKTAQLKALSTC | 231 | Q8NGK6 | |
| KSLASFKSNECLVSD | 421 | Q59EK9 | |
| DTCNSSLASLRLKSK | 276 | P78337 | |
| KSLSCSLEVSKDSRT | 266 | Q8IUD6 | |
| SNNSTSKRKSESATC | 481 | P12757 | |
| SKRKSESATCNLVRD | 486 | P12757 | |
| SLEKQTRSKYCTETS | 66 | O95425 | |
| ETSFDFKCSQSRLKT | 326 | Q6NW34 | |
| RCLSSSKNTLKDSLF | 221 | Q9P0U3 | |
| HSVRSSEDKTSKSSC | 316 | O94768 | |
| SNLSDLKECSGSRKA | 296 | Q9Y371 | |
| SSCFGDSTKSRTKLV | 81 | Q13228 | |
| KKDDSTCNSTVETRA | 321 | Q9HB58 | |
| PSASQRKKAFSTCSS | 226 | Q9NZP0 | |
| LRDSKSSDKSVCLFT | 11 | P01848 | |
| SSSRQLSESFKSKEF | 651 | Q08945 | |
| LQSCESSKSKSQLTS | 446 | A6NIR3 | |
| ASQCKKLRSSFESSC | 76 | Q5JTJ3 | |
| NECGKTFSRKSSLTR | 526 | Q96IR2 | |
| KTVKNRSCVYSSSAE | 1191 | Q5VYP0 | |
| TKSSSKLSSCIAAIA | 261 | Q9HCE3 | |
| RCSKESLKNSATEAA | 701 | P42285 | |
| KTVKNRSCVYSSSAE | 1191 | Q5TZJ5 | |
| CSIANSKTSNTLEKD | 196 | Q8WU79 | |
| LRDSKSSDKSVCLFT | 146 | P0DTU3 | |
| NECGKSFSRKSALSD | 376 | Q9NYW8 | |
| KCKACSKSFTRSSNL | 381 | Q14586 | |
| SLKVQESSRDCALSS | 351 | Q96GC6 | |
| SKTLCKDSPEAQSSR | 226 | A7MD48 | |
| SSSSCLTENSLKINK | 346 | Q6ZV73 | |
| KKSSSEASLEAALCL | 271 | A2RTY3 | |
| KARASPSVTCKSSSE | 1281 | O15014 | |
| CSSSILSGKASSEKE | 516 | Q6AHZ1 | |
| QSCKSETLGSRDSAL | 351 | Q96JE7 | |
| SVSSRSIFKDKQSCD | 96 | P21506 | |
| SKEKLDSNSNCLSSV | 561 | Q8N9V7 | |
| LECDKAFSQSSTLTK | 516 | Q9H8G1 | |
| ASCSTARQTKQKRKS | 6 | Q9Y2I8 | |
| SFKTTTSRAACQLVK | 136 | Q9Y2I8 | |
| FTFKSKSSLALCLDS | 636 | Q86T82 | |
| KECGKAFNRSSTLTS | 316 | Q86V71 | |
| CRECKKTFTESSSLA | 301 | P0CG31 | |
| KSTTCTRFFKNLASS | 251 | Q6NUS6 | |
| SITCLSKACASSDKQ | 66 | Q9Y4E6 | |
| LAKLTDSFKNSCSVT | 171 | Q9ULE0 | |
| TKLSSGSKRCSEDFS | 886 | Q7Z3T8 | |
| EKITCSSSKRNEFKS | 81 | O76095 | |
| SSSKRNEFKSCRSAL | 86 | O76095 | |
| ISSPKARTKNEACSS | 391 | Q58DX5 | |
| SKTSASIGSLCADAR | 191 | P60201 |